Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dixon

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
The Pediatric Infectious Disease Journal|February 14, 2025
Vaccination During Pregnancy in the Vaccine Safety Datalink, 2002-2022Allison L Naleway, Bradley Crane, Stephanie A Irving, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Pediatrics|May 5, 2025
Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024Stephanie A Irving, Bradley Crane, Eric S Weintraub, et al.
Lancet Regional Health. Americas|October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysisAmanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
The Pediatric Infectious Disease Journal|February 14, 2025
Vaccination During Pregnancy in the Vaccine Safety Datalink, 2002-2022Allison L Naleway, Bradley Crane, Stephanie A Irving, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Pediatrics|May 5, 2025
Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024Stephanie A Irving, Bradley Crane, Eric S Weintraub, et al.
Lancet Regional Health. Americas|October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysisAmanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
Pageof 13